Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002007726 | SCV002259759 | uncertain significance | not provided | 2022-07-12 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs758978508, gnomAD 0.006%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1474835). This variant has not been reported in the literature in individuals affected with NEUROG3-related conditions. This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 131 of the NEUROG3 protein (p.Tyr131Cys). |
Fulgent Genetics, |
RCV002484884 | SCV002793835 | uncertain significance | Congenital malabsorptive diarrhea 4 | 2022-04-07 | criteria provided, single submitter | clinical testing | |
Undiagnosed Diseases Network, |
RCV002484884 | SCV002818568 | uncertain significance | Congenital malabsorptive diarrhea 4 | 2022-05-10 | no assertion criteria provided | clinical testing |